Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Alginates × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 2765 Cisplatin 2745 Carboplatin 2550 Radiotherapy 2353 Paclitaxel 2334 Gemcitabine 2203 pembrolizumab 2026 Docetaxel 1910 Bevacizumab 1853 Fluorouracil 1610 Capecitabine 1575 Oxaliplatin 1496 Dexamethasone 1379 Nivolumab 1313 Doxorubicin 1292 Rituximab 1278 Etoposide 1179 Magnetic Resonance Spectroscopy 1098 Irinotecan 1085 Leucovorin 1069 Cytarabine 994 Drug Therapy 923 fludarabine 918 Pemetrexed 911 Vincristine 823 Prednisone 814 Lenalidomide 808 Cetuximab 797 Specimen Handling 794 Filgrastim 790

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡